Dysmenorrhea, or painful menstruation, is a common gynecological concern that can interfere with daily activities, work, education, and quality of life. Primary dysmenorrhea typically occurs without underlying pelvic pathology and is associated with increased prostaglandin activity, uterine contractions, and menstrual pain. Methi (Trigonella foenum-graecum L.), commonly known as fenugreek, is used in traditional medicine and contains bioactive compounds with potential anti-inflammatory and analgesic properties. Clinical studies have investigated fenugreek seeds for menstrual pain relief; however, the evidence remains limited, and methi is not an established first-line treatment for dysmenorrhea.1,2
Traditional use and potential mechanisms
- Fenugreek seeds have been used in traditional medicinal preparations, and their potential analgesic and anti-inflammatory effects have prompted investigation for menstrual discomfort.1
- Fenugreek contains soluble fiber and phytochemicals, including saponins, flavonoids, and alkaloids, although their specific contribution to menstrual pain relief has not been established.
- Experimental findings suggest possible anti-inflammatory activity, but a clinically meaningful effect on prostaglandin pathways or uterine contractions in humans remains uncertain.
- Traditional use and biological plausibility should not be interpreted as proof of efficacy or as evidence that all fenugreek preparations produce equivalent effects.
Clinical evidence for dysmenorrhea
- A randomized, double-blind, placebo-controlled trial published in 2014 reported reduced pain severity and improvements in associated symptoms, including fatigue, headache, nausea, and vomiting, among participants receiving fenugreek seed powder.2
- A 2024 systematic review and meta-analysis included four studies and reported lower pain intensity with fenugreek than with placebo; however, the authors rated the overall evidence as low quality and emphasized substantial uncertainty.1
- The limited number of studies, differences in interventions and comparators, and uncertainty regarding long-term outcomes restrict the generalizability of the findings.
- Current evidence does not establish fenugreek as equivalent or superior to established treatments, and it does not support replacing recommended medical management with herbal supplementation.
Safety considerations and precautions
- Reported adverse effects of oral fenugreek include gastrointestinal discomfort, diarrhea, nausea, and allergic reactions, while concentrated preparations may have different safety profiles from culinary use.3
- Fenugreek may lower blood glucose, so concurrent use with glucose-lowering medications warrants caution because of a potential additive effect.3
- Potential interactions with medications, including those affecting blood clotting, should be reviewed before medicinal use because the clinical significance and magnitude of these interactions are not fully established.
- Fenugreek should not be used in medicinal amounts during pregnancy because safety concerns have been reported, including a possible increased risk of birth defects.3
- Persistent, severe, worsening, or newly developed menstrual pain warrants clinical assessment for secondary causes, including endometriosis, adenomyosis, or pelvic infection.
Clinical considerations
|
Clinical situation |
Appropriate consideration |
|
Pain affecting daily activities |
Assess severity, functional impact, menstrual history, and response to treatment. |
|
Suspected secondary dysmenorrhea |
Investigate the underlying cause rather than relying on herbal remedies alone. |
|
Concurrent medication use |
Review potential interactions and relevant medical conditions before recommending supplements. |
|
Interest in herbal treatment |
Discuss the limited evidence, uncertain product quality, and potential adverse effects. |
Conclusion
Methi may offer a potential supportive option for menstrual comfort, but current evidence is insufficient to establish its efficacy and safety as a treatment for dysmenorrhea. Small clinical studies suggest possible pain reduction, yet the overall certainty of evidence remains low. Clinicians should discuss realistic expectations, review contraindications and interactions, and prioritize established management strategies while investigating persistent or atypical menstrual pain.
References
- Hassanzadeh R, Shabani F, Montazeri M, Mirghafourvand M. The effect of fenugreek on the severity of dysmenorrhea: A systematic review and meta-analysis. Curr Drug Res Rev. 2024;16(2):219-227. doi:10.2174/2589977515666230818092814. https://pubmed.ncbi.nlm.nih.gov/37594100/
- Younesy S, Amiraliakbari S, Esmaeili S, Alavidashahi S, Kanani M. Effects of fenugreek seed on the severity and systemic symptoms of dysmenorrhea. J Reprod Infertil. 2014;15(1):41-48. https://pmc.ncbi.nlm.nih.gov/articles/PMC3955423/
- National Center for Complementary and Integrative Health. Fenugreek: Usefulness and safety. Accessed October 27, 2026. https://www.nccih.nih.gov/health/fenugreek